Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2)

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2023
This article has no abstract
Epistemonikos ID: 7b1c9bdda21c2a3691b9a723e98e0a5cd2e6fc2a
First added on: Mar 21, 2025